Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes

Eur J Sport Sci. 2019 Oct;19(9):1276-1286. doi: 10.1080/17461391.2019.1587522. Epub 2019 Mar 18.

Abstract

Growing analytical challenges have arisen for the detection of misuse of androgenic anabolic steroids (AAS) in athletes the last years. Therefore, consideration of additional indirect markers can substantially aid the efforts to detect AAS abuse in athletes. Moreover, this approach can also help physicians to suspect AAS abuse when treating athletes. Laboratory markers highly indicative of AAS abuse in athletes include the considerable downregulation of high density lipoprotein-cholesterol, elevation of haematocrit or serum γ-glutamyl transpeptidase levels and for males reduced serum levels of both luteinizing hormone and follicle-stimulating hormone. Moreover, physical signs suggestive of current AAS abuse are hypertension, apparent changes in behaviour making the athlete more irritable and aggressive and the sudden appearance of acne vulgaris in an adult athlete with no recent history of acne, while testicular atrophy and gynecomastia raise suspicion of current or past AAS abuse in male athletes.

Keywords: anabolic steroid abusers; antidoping control; diagnostic markers.

Publication types

  • Review

MeSH terms

  • Acne Vulgaris
  • Anabolic Agents / administration & dosage*
  • Athletes
  • Biomarkers / analysis*
  • Cholesterol, HDL / blood
  • Doping in Sports*
  • Female
  • Follicle Stimulating Hormone / blood
  • Hematocrit
  • Humans
  • Luteinizing Hormone / blood
  • Male
  • Substance-Related Disorders / diagnosis*
  • Testosterone Congeners / administration & dosage*
  • gamma-Glutamyltransferase / blood

Substances

  • Anabolic Agents
  • Biomarkers
  • Cholesterol, HDL
  • Testosterone Congeners
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • gamma-Glutamyltransferase